Skip to main content
Equibles

Squarepoint Ops LLC

Position in MYGN — Myriad Genetics Inc

CIK 1642575 NEW YORK, NY
Back to MYGN Full portfolio

Position in MYGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,190,921
-$135,561 QoQ
Shares Held
383,699
-25.8% QoQ
Ownership
0.401%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#39
of 196 holders
Holding Since
Jun 2020
18 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $771,534,982 across 27 Diagnostics & Research names. MYGN ranks #16 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IDXX
Idexx Laboratories Inc /De
 315,164 $165,914,936
2 DHR
Danaher Corp /De/
 702,933 $133,894,677
3 NTRA
Natera, Inc.
 336,268 $91,279,948
4 GH
Guardant Health, Inc.
 580,133 $87,037,353
5 TMO
Thermo Fisher Scientific Inc.
 167,029 $83,741,659
6 LH
Labcorp Holdings Inc.
 258,438 $72,362,640
7 A
Agilent Technologies, Inc.
 466,294 $61,937,832
8 DGX
Quest Diagnostics Inc
 117,831 $24,974,280

All Filings in MYGN

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,190,921 383,699
2026-03-31 $2,326,482 516,996
2025-12-31 $2,114,019 343,743
2025-09-30 $855,359 118,307
2025-06-30 $787,658 148,335
2025-03-31 $710,726 80,127
2024-12-31 $1,903,893 138,869
2024-09-30 $2,994,959 109,345
2024-06-30 $667,415 27,286
2024-03-31 $1,845,800 86,576
2023-12-31 $784,816 41,004
2023-09-30 $396,813 24,739
2023-06-30 $350,968 15,141
2023-03-31 $619,288 26,659
2022-12-31 $2,414,231 166,384
2022-09-30 $493,943 25,888
2020-09-30 $467,640 35,862
2020-06-30 $987,181 87,053